United States · FDA National Drug Code directory
Cephalexin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0093-4177_c75c0bb6-fe3e-43c6-bdde-edd904731795
- Product NDC
- 0093-4177
- Form
- POWDER, FOR SUSPENSION
- Composition / generic term
- Cephalexin
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 19900930
- Source listing expiry
- 20261231
Source-listed ingredients
- CEPHALEXIN — 250 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 100 mL in 1 BOTTLE (0093-4177-73) · 0093-4177-73
- 200 mL in 1 BOTTLE (0093-4177-74) · 0093-4177-74
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →